The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Eremina A.A.

Novosibirsk State University

Korolev M.A.

Novosibirsk State University;
Research Institute of Clinical and Experimental Lymphology — Federal Research Center Institute of Cytology and Genetics Siberian Branch Russian Academy of Sciences

Letyagina E.A.

Novosibirsk State University;
Research Institute of Clinical and Experimental Lymphology — Federal Research Center Institute of Cytology and Genetics Siberian Branch Russian Academy of Sciences

Rybakova A.D.

Novosibirsk State University;
Research Institute of Clinical and Experimental Lymphology — Federal Research Center Institute of Cytology and Genetics Siberian Branch Russian Academy of Sciences

Sergeeva I.G.

Novosibirsk State University

Clinical discussion of patients with follicular occlusion syndrome and comorbid pathology

Authors:

Eremina A.A., Korolev M.A., Letyagina E.A., Rybakova A.D., Sergeeva I.G.

More about the authors

Read: 441 times


To cite this article:

Eremina AA, Korolev MA, Letyagina EA, Rybakova AD, Sergeeva IG. Clinical discussion of patients with follicular occlusion syndrome and comorbid pathology. Russian Journal of Clinical Dermatology and Venereology. 2025;24(5):596‑603. (In Russ.)
https://doi.org/10.17116/klinderma202524051596

Recommended articles:
Clinical features of severe acne and gene­tic dete­rminants of therapeutic effi­cacy of systemic isotretinoin. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):30-37
Dissecting cellulitis of the scalp (Hoffman’s disease): a clinical case. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):45-48
Psychodermatological aspe­cts of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):403-411
Study of the role of inte­rleukin-1β in blood serum in patients with acne. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):421-424
Adhe­rence of patients to acne therapy using systemic isotretinoin. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):483-488
Rational choice of combined therapy of acne: systemic isotretinoin and high-energy hardware technologies. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):651-656

References:

  1. Jastrząb B, Szepietowski JC, Matusiak Ł. Hidradenitis suppurativa and follicular occlusion syndrome: Where is the pathogenetic link? Clin Dermatol. 2023 Sep-Oct;41(5):576-583.  https://doi.org/10.1016/j.clindermatol.2023.08.021
  2. Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec GB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):50-61.  https://doi.org/10.1111/jdv.16677
  3. Frew JW. Hidradenitis suppurativa is an autoinflammatory keratinization disease: A review of the clinical, histologic, and molecular evidence. JAAD Int. 2020 Jun 27;1(1):62-72.  https://doi.org/10.1016/j.jdin.2020.05.005
  4. Garg A, Neuren E, Cha D, Kirby JS, Ingram JR, Jemec GBE, Esmann S, Thorlacius L, Villumsen B, Marmol VD, Nassif A, Delage M, Tzellos T, Moseng D, Grimstad Ø, Naik H, Micheletti R, Guilbault S, Miller AP, Hamzavi I, van der Zee H, Prens E, Kappe N, Ardon C, Kirby B, Hughes R, Zouboulis CC, Nikolakis G, Bechara FG, Matusiak L, Szepietowski J, Glowaczewska A, Smith SD, Goldfarb N, Daveluy S, Avgoustou C, Giamarellos-Bourboulis E, Cohen S, Soliman Y, Brant EG, Akilov O, Sayed C, Tan J, Alavi A, Lowes MA, Pascual JC, Riad H, Fisher S, Cohen A, Paek SY, Resnik B, Ju Q, Wang L, Strunk A. Evaluating patients’ unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project. J Am Acad Dermatol. 2020 Feb;82(2):366-376.  https://doi.org/10.1016/j.jaad.2019.06.1301
  5. Melnik BC, John SM, Chen W, Plewig G. T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities. Br J Dermatol. 2018 Aug;179(2):260-272.  https://doi.org/10.1111/bjd.16561
  6. Fletcher JM, Moran B, Petrasca A, Smith CM. IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa. Clin Exp Immunol. 2020 Aug;201(2):121-134.  https://doi.org/10.1111/cei.13449
  7. Phan K, Tatian A, Woods J, Cains G, Frew JW. Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta-analysis. Int J Dermatol. 2020 Feb;59(2):221-228.  https://doi.org/10.1111/ijd.14697
  8. Richette P, Molto A, Viguier M, Dawidowicz K, Hayem G, Nassif A, Wendling D, Aubin F, Lioté F, Bachelez H. Hidradenitis suppurativa associated with spondyloarthritis -- results from a multicenter national prospective study. J Rheumatol. 2014 Mar;41(3):490-494.  https://doi.org/10.3899/jrheum.130977
  9. Kridin K, Shani M, Schonmann Y, Fisher S, Shalom G, Comaneshter D, Batat E, Cohen AD. Psoriasis and hidradenitis suppurativa: A large-scale population-based study. J Am Acad Dermatol. 2023 May;88(5):e231-e236. https://doi.org/10.1016/j.jaad.2018.11.036
  10. Mendes-Bastos P, Benhadou F, Venturini M, Molina-Levya A, Thomas N, Alarcon I, Bechara FG. Biologic drugs in hidradenitis suppurativa: what does the GP have to know? A narrative review. Front Med (Lausanne). 2024 Jul 8;11:1403455. https://doi.org/10.3389/fmed.2024.1403455
  11. Chiu YM, Chen DY. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics. Expert Rev Clin Immunol. 2020 Feb;16(2):207-228.  https://doi.org/10.1080/1744666X.2019.1705785
  12. Zouboulis CC, Passeron T, Pariser D, Wozniak MB, Li X, Uhlmann L, Lobach I, Martinez AL, Ravichandran S, Alarcon I, Offidani A, Alam MS, Mendes-Bastos P. Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials. Br J Dermatol. 2024 May 17;190(6):836-845.  https://doi.org/10.1093/bjd/ljae098
  13. Li M, Xiang H, Liang Y, Xue L, Zhou X, Yang L, Liu H, Yang M, Tang J, Li W. Secukinumab for PASS syndrome: A new choice for therapeutic challenge? Dermatol Ther. 2022 Jul;35(7):e15507. https://doi.org/10.1111/dth.15507
  14. Nazary M, Prens EP, Boer J. Azathioprine lacks efficacy in hidradenitis suppurativa: a retrospective study of nine patients. Br J Dermatol. 2016 Mar; 174(3):639-641.  https://doi.org/10.1111/bjd.14086
  15. López Riquelme I, Fernández Ballesteros MD, Perea Polak A, Serrano Ordoñez A, Martínez Pilar L. Azathioprine in hidradenitis suppurativa with inflammatory phenotype: a case series of 11 patients. Int J Dermatol. 2023 Oct;62(10):1300-1303. https://doi.org/10.1111/ijd.16804
  16. Megna M, Ruggiero A, Di Guida A, Patrì A, Fabbrocini G, Marasca C. Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa. Dermatol Ther. 2020 Jul;33(4):e13756. https://doi.org/10.1111/dth.13756
  17. Ruggiero A, Martora F, Picone V, Marano L, Fabbrocini G, Marasca C. Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review. Biomedicines. 2022 Feb 16;10(2):455.  https://doi.org/10.3390/biomedicines10020455
  18. Faivre C, Villani AP, Aubin F, Lipsker D, Bottaro M, Cohen JD, Durupt F, Jeudy G, Sbidian E, Toussirot E, Badot V, Barbarot S, Debarbieux S, Delaporte E, Goegebeur G, Morel J, Nassif A, Duru G, Jullien D; French Society of Dermatology and Club Rheumatisms and Inflammation. Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases. J Am Acad Dermatol. 2016 Jun;74(6):1153-1159. https://doi.org/10.1016/j.jaad.2016.01.018

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.